Summaries & Highlights

33766 views 3878 hours watched
19:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 H&N Cancer Highlights: Key Insights From Clinical Trials

FEATURING Katie Kerrigan
  • 194 views
  • August 27, 2024
24:36

2024 ASCO® Annual Meeting Insights Hub

ASCO 2024 Highlights: Insights From Key Abstracts on mBC

FEATURING Sramila Aithal
  • 168 views
  • August 27, 2024
  • 2
15:07

2024 ASCO® Annual Meeting Insights Hub

Highlights of Recent Updates in CML: Impact on Practice

FEATURING Ehab Atallah
  • 44 views
  • August 27, 2024
18:08

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarcomas

FEATURING Atif Hussein
  • 158 views
  • August 12, 2024
  • 1
17:22

2024 ASCO® Annual Meeting Insights Hub

Highlights of Recent Updates in Myeloma: Part 2 - R/R Treatment

FEATURING Andrzej Jakubowiak
  • 249 views
  • July 31, 2024
  • 2
19:20

2024 ASCO® Annual Meeting Insights Hub

Highlights of Recent Updates in Myeloma: Part 1 - Frontline Treatment

FEATURING Andrzej Jakubowiak
  • 291 views
  • July 31, 2024
  • 3
21:54

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Prostate Cancer Take-Home Messages

FEATURING Eleni Efstathiou
  • 606 views
  • July 29, 2024
  • 2
14:45

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

FEATURING Mansoor Raza Mirza
  • 1,000 views
  • June 18, 2024
  • 5
24:57

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8HW, NEOPRISM, and PanaMa"

FEATURING Richard Kim, Tiago Biachi
  • 555 views
  • June 20, 2024
  • 4
12:14

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breast06, postMONARCH, A-BRAVE, Dato/Durva in I-SPY 2.2, and SACI-IO HR+

FEATURING Paolo Tarantino
  • 2,076 views
  • June 21, 2024
  • 16
21:12

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

FEATURING Nabil Saba
  • 1,030 views
  • June 13, 2024
  • 5
10:19

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications for the Practicing Oncologist"

FEATURING Kriti Mittal
  • 363 views
  • July 16, 2024
  • 4
16:57

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NSCLC), HERKULES-3 Trial (CRC), Novel Agents in ER+/HER2- BC

FEATURING Vivek Subbiah
  • 678 views
  • June 14, 2024
  • 5
25:08

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

FEATURING Sara Tolaney, Hope Rugo
  • 4,077 views
  • June 7, 2024
  • 30
16:57

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Lymphoma Highlights"

FEATURING Bruce D. Cheson
  • 1,237 views
  • June 19, 2024
  • 2
22:27

2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

FEATURING Guru Sonpavde
  • 533 views
  • July 5, 2024
  • 1
36:14

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, ADRIATIC, KRYSTAL-12, and LAURA Trials

FEATURING Balazs Halmos
  • 810 views
  • June 21, 2024
  • 11
16:10

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOMA-3 Trials

FEATURING Luis Raez
  • 679 views
  • June 14, 2024
  • 4
09:06

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

FEATURING Ritu Salani
  • 1,583 views
  • July 1, 2024
  • 12
17:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinical Utility of ctDNA"

FEATURING Stacey Cohen
  • 348 views
  • June 17, 2024
  • 1
25:29

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Insights in Melanoma"

FEATURING Omid Hamid
  • 459 views
  • June 21, 2024
  • 5
16:37

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Highlights in Sarcomas

FEATURING Robin Jones
  • 219 views
  • July 12, 2024
  • 1
15:28

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Bladder and RCC Highlights"

FEATURING Karine Tawagi, Natalie Reizine
  • 262 views
  • July 16, 2024
  • 4
09:25

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including TRANSMET and ARC-9 Trials"

FEATURING Nataliya Uboha, Kristen Spencer, Michael Cecchini
  • 352 views
  • June 10, 2024
  • 1
09:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancers Including ESOPEC and ARMANI Trials"

FEATURING Nataliya Uboha, Anita Turk, Kristen Spencer, Michael Cecchini
  • 537 views
  • June 10, 2024
  • 4
35:23

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

FEATURING Sapna Patel
  • 771 views
  • July 11, 2024
  • 3
27:49

Insights from 2024 EHA Annual Meeting

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

FEATURING Talha Badar
  • 704 views
  • July 16, 2024
  • 4
12:29

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

FEATURING Cathy Eng
  • 203 views
  • July 9, 2024
  • 2
17:22

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "SCLC Treatment Evolution - Debunking Myths, IO Advances, and Long-Term Strategies"

FEATURING Anne Chiang
  • 406 views
  • July 10, 2024
  • 2
11:57

COR2ED The Heart of Medical Education

ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Cancer, NSCLC, HCC, and Upper-GI Cancers"

FEATURING Mark Socinski, Peter R. Galle, Shaheenah Dawood, Elizabeth Smyth, Samuel Klempner
  • 172 views
  • July 9, 2024
  • 3
08:19

COR2ED The Heart of Medical Education

ASCO® 2024 Summary: "Latest Practice-Changing Data in Gastroesophageal and Colorectal Cancers"

FEATURING Elizabeth Smyth, Samuel Klempner, Jenny Seligmann, Dominik Modest
  • 190 views
  • July 8, 2024
  • 1
34:26

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Prostate Cancer Highlights"

FEATURING Natalie Reizine, Karine Tawagi
  • 566 views
  • July 10, 2024
  • 2
33:44

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clinical Implications"

FEATURING Sara Tolaney, Hope Rugo
  • 919 views
  • July 4, 2024
  • 5
12:49

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment of Relapsed HL - Updated Options in Light of New Frontline Therapies"

FEATURING Patrick Johnson
  • 434 views
  • June 7, 2024
  • 5
05:26

ecancer

ASCO® 2024 Lung Cancer Updates: CROWN, ADRIATIC, and LAURA Trials

FEATURING Luis Raez
  • 66 views
  • July 2, 2024
  • 1
40:00

ecancer

ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials

FEATURING Bishal Gyawali
  • 97 views
  • July 2, 2024
  • 1
24:27

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuvant Treatments, 1L Metastatic & Anti-PD-1 Refractory Disease"

FEATURING Zeynep Eroglu
  • 326 views
  • July 5, 2024
  • 3
24:35

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstracts"

FEATURING Hamza Hashmi
  • 616 views
  • July 1, 2024
  • 5
20:41

2024 ASCO® Annual Meeting Insights Hub

Bladder Cancer Highlights From ASCO® 2024

FEATURING Guru Sonpavde
  • 1,402 views
  • June 10, 2024
  • 9
13:15

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Quadruplets in NDMM - The More the Better?"

FEATURING Ola Landgren
  • 414 views
  • June 12, 2024
  • 7
11:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and Refractory Melanoma"

FEATURING Douglas Johnson
  • 475 views
  • June 7, 2024
  • 1
25:55

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "News in Head&Neck Cancers"

FEATURING Paolo Bossi
  • 483 views
  • June 14, 2024
  • 11
17:07

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their Management With Bispecific Agents in MM and B-Cell NHL"

FEATURING Monique Minnema
  • 282 views
  • June 7, 2024
  • 4
19:49

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Advances in RCC and Urothelial Carcinoma - Key Updates From the CheckMate 9ER, JAVELIN Renal 101, and CheckMate 901 Trials"

FEATURING Camillo Porta
  • 91 views
  • June 26, 2024
  • 1
36:10

Insights from 2024 EHA Annual Meeting

Highlights in Plasma Cell Disorders From ASCO® and EHA

FEATURING Samer Al Hadidi
  • 466 views
  • June 27, 2024
  • 7
15:45

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Experts Discuss Key Updates in Colorectal Cancer"

FEATURING Sakti Chakrabarti, Aditya Shreenivas
  • 390 views
  • June 26, 2024
13:15

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endometrial and Ovarian Cancers"

FEATURING Amer Karam
  • 421 views
  • June 26, 2024
  • 5
19:33

ecancer

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

FEATURING Enriqueta Felip, Alex Spira, Antonio Passaro, Alfredo Addeo
  • 499 views
  • June 21, 2024
  • 1
15:57

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment Strategies and QoL Impact in mCRPC - Key Updates From the MANCAN2, EMBARK, PRESTO, and PSMAfore Trials"

FEATURING Channing Paller
  • 170 views
  • June 26, 2024
  • 2
26:40

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Experts Discuss Key Updates in Gastroesophageal Cancers"

FEATURING Aditya Shreenivas, Sakti Chakrabarti
  • 133 views
  • June 26, 2024
19:14

2024 ASCO® Annual Meeting Insights Hub

Experts Discuss Highlights and Key Takeaways in CLL From ASCO® and EHA

FEATURING Kerry Rogers, Jennifer Woyach
  • 306 views
  • June 21, 2024
  • 1
08:52

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Updates in Frontline Management of GE Cancers - Beyond PD-1"

FEATURING Raghav Sundar
  • 126 views
  • June 25, 2024
  • 1
06:51

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Biliary Tract Cancer"

FEATURING Arndt Vogel
  • 91 views
  • June 25, 2024
22:22

ecancer

ASCO® 2024 Summary: "Expert Panel Discussion on Best Practices in HRRm Testing in Patients With Metastatic Prostate Cancer"

FEATURING Martin Schostak, Alexander Wyatt, Charles Ryan, Emmanuel Antonarakis
  • 181 views
  • June 24, 2024
09:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and CARES-310 Studies"

FEATURING Arndt Vogel
  • 213 views
  • June 25, 2024
  • 1
27:39

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Upper-GI Key Studies Including ESOPEC and RENAISSANCE"

FEATURING Richard Kim, Rutika Mehta
  • 154 views
  • June 21, 2024
  • 2
12:37

ecancer

ASCO® 2024 Summary: "IMROZ & BENEFIT Studies in Newly Diagnosed Myeloma"

FEATURING Xavier Leleu
  • 182 views
  • June 24, 2024
  • 1
17:44

ecancer

ASCO® 2024 Summary: "Expert Panel Discussion on the Real World Evidence on PSA Testing in Prostate Cancer"

FEATURING Friederike Schlürmann, Boris Hadaschik, Karim Fizazi
  • 192 views
  • June 24, 2024
12:10

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "BEAT Trials and Neoadjuvant Strategies - Advances in ES-SCLC and Mesothelioma Treatment"

FEATURING Melina Marmarelis
  • 247 views
  • June 20, 2024
  • 1
11:27

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We Been and Where Are We"

FEATURING Pippa Corrie
  • 283 views
  • June 20, 2024
  • 1
09:24

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment and Outcomes in Select Subpopulations With Breast Cancer"

FEATURING Lisa Carey
  • 345 views
  • June 18, 2024
  • 2
25:09

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

FEATURING Richard Kim, Tiago Biachi
  • 375 views
  • June 20, 2024
  • 1
21:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "The Art and Science of Caring for Older Adults With Myeloid Malignancies"

FEATURING Kah Poh Loh
  • 96 views
  • June 16, 2024
14:59

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Current Status of Bispecific Antibody Therapy in R/R MM"

FEATURING Meera Mohan
  • 141 views
  • June 16, 2024
  • 1
14:58

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Optimal Treatment Strategies for Younger Patients With AML - Intensive vs. Non-Intensive Approaches"

FEATURING Christine McMahon
  • 288 views
  • June 20, 2024
  • 1
16:18

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Understanding New Strategies to Prevent and Manage Chronic GVHD"

FEATURING Betty Hamilton
  • 70 views
  • June 16, 2024
09:13

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary Cancer Including CheckMate 9DW and ABC-07 Trials"

FEATURING Nataliya Uboha, Kristen Spencer, Michael Cecchini
  • 230 views
  • June 10, 2024
  • 1
20:16

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Immunotherapy & Beyond - Advances in Systemic Therapy for Patients With Melanoma and Brain Metastases"

FEATURING Hussein Tawbi
  • 185 views
  • June 12, 2024
  • 1
17:34

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment Considerations for Challenging Populations With Hodgkin Lymphoma"

FEATURING Cathy Burton
  • 115 views
  • June 10, 2024
12:38

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Refining Treatment in Advanced Hepatobiliary Cancers"

FEATURING Laura Goff
  • 80 views
  • June 12, 2024
15:18

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Adopting Cutting-Edge Cell Therapies in Melanoma"

FEATURING Allison Betof Warner
  • 190 views
  • June 11, 2024
01:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Unveiling the Unique Identity of Clear-Cell Endometrial Cancer - A Comprehensive Comparative Analysis With Ovarian Counterpart and Other Endometrial Subtypes"

FEATURING Felix Blanc-Durand
  • 141 views
  • June 11, 2024
  • 1
11:33

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "PD-1-Refractory Advanced Melanoma - Getting to the Finish Line"

FEATURING Meredith Mckean
  • 145 views
  • June 10, 2024
  • 3
20:16

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Immunotherapy & Beyond - Advances in Systemic Therapy for Patients With Melanoma and Brain Metastases"

FEATURING Hussein Tawbi
  • 185 views
  • June 12, 2024
  • 1

Breast

16169 views 1554 hours watched
24:36

2024 ASCO® Annual Meeting Insights Hub

ASCO 2024 Highlights: Insights From Key Abstracts on mBC

FEATURING Sramila Aithal
  • 168 views
  • August 27, 2024
  • 2
09:34

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Impact of ctDNA Surveillance on Clinical Care for Patients With Stage I-III BC"

FEATURING Marla Lipsyc-Sharf
  • 298 views
  • July 24, 2024
  • 1
05:06

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Genomic Alterations in HR+/HER2- Metastatic Breast Cancer - Co-Occurrence and Prevalence Across Treatment"

FEATURING Manali Bhave
  • 464 views
  • July 10, 2024
15:31

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Young-PEARL Study - Palbociclib + Exemestane With GnRH Agonist vs. Capecitabine in Premenopausal Patients With HR+/HER2- mBC"

FEATURING Yeon Hee Park
  • 248 views
  • July 10, 2024
  • 2
33:44

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clinical Implications"

FEATURING Sara Tolaney, Hope Rugo
  • 919 views
  • July 4, 2024
  • 5
09:30

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "EMBER Study - Imlunestrant, an Oral SERD, in Combination With HER2 Directed Therapy +/- Abemaciclib in ER+/HER2+ Advanced BC"

FEATURING Manali Bhave
  • 87 views
  • July 2, 2024
27:15

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Management of Higher Risk eBC Including BRCAm, HER2- Subtypes"

FEATURING Milana Dolezal
  • 350 views
  • July 2, 2024
  • 3
04:35

ecancer

ASCO® 2024 Insights: "Avelumab in Early TNBC With Residual Disease After Neoadjuvant Chemo or at High Risk After Primary Surgery and Adjuvant Chemo"

FEATURING Pierfranco Conte
  • 70 views
  • July 2, 2024
07:02

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "postMONARCH Trial - Abemaciclib + Fulvestrant vs. Fulvestrant Alone for HR+/HER2- Advanced BC Following Progression on a Prior CDK4/6i + ET"

FEATURING Kevin Kalinsky
  • 356 views
  • July 2, 2024
  • 1
02:48

ecancer

ASCO® 2024 Insights: "Clinical Behavior and Prognostic Impact of Genetic Testing in Young BRCA Breast Cancer Patients"

FEATURING Matteo Lambertini
  • 83 views
  • July 2, 2024
  • 1
04:11

ecancer

ASCO® 2024 Insights: "INAVO-PBO Trial - 1L Inavolisib/Placebo + Palbo + Fulv in Patients With PIK3CAm, HR+/HER2‑ Locally Advanced/Metastatic BC Who Relapsed During/Within 12 Months of Adjuvant ET Completion"

FEATURING Dejan Juric
  • 131 views
  • July 2, 2024
  • 1
12:14

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breast06, postMONARCH, A-BRAVE, Dato/Durva in I-SPY 2.2, and SACI-IO HR+

FEATURING Paolo Tarantino
  • 2,076 views
  • June 21, 2024
  • 16
25:08

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

FEATURING Sara Tolaney, Hope Rugo
  • 4,077 views
  • June 7, 2024
  • 30
04:04

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Updated Survival Data in DESTINY-Breast03 Trial - T-DXd vs. T-DM1 in Patients With HER2+ mBC"

FEATURING Erika Hamilton
  • 362 views
  • June 18, 2024
04:07

ecancer

ASCO® 2024 Insights: "I-SPY2.2 Trial - Pathologic Response to Neoadjuvant Datopotamab Deruxtecan in Breast Cancer"

FEATURING Jane Meisel
  • 235 views
  • June 20, 2024
09:55

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

FEATURING Erika Hamilton
  • 1,416 views
  • June 18, 2024
  • 7
03:01

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "H3B-6545 in Women With ER+/HER2- mBC"

FEATURING Erika Hamilton
  • 27 views
  • June 18, 2024
14:45

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Elucidating the Immune Active State of HR+/HER2- MammaPrint High 2 Early BC"

FEATURING Erin Cobain
  • 353 views
  • June 18, 2024
  • 3
09:26

2024 ASCO® Annual Meeting Insights Hub

DESTINY-Breast06 - T-DXd vs. Physician’s Choice of Chemotherapy in HR+/HER2-Low/Ultralow mBC After Endocrine Therapy

FEATURING Giuseppe Curigliano
  • 706 views
  • June 18, 2024
  • 4
09:24

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment and Outcomes in Select Subpopulations With Breast Cancer"

FEATURING Lisa Carey
  • 345 views
  • June 18, 2024
  • 2
05:16

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "JBCRG-M06/EMERALD Trial - Trastuzumab & Pertuzumab in Combination With Eribulin Mesylate or a Taxane as 1L Chemotherapeutic Treatment for HER2+ Stage 3/4 BC"

FEATURING Toshinari Yamashita
  • 96 views
  • June 17, 2024
11:07

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Ultra-Sensitive ctDNA Mutation Tracking to Identify MRD and Predict Relapse in Patients With Early BC"

FEATURING Isaac Garcia-Murillas
  • 700 views
  • June 17, 2024
  • 1
11:13

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Development and Validation of RSClinN+ Tool for HR+/HER2- Node-Positive BC"

FEATURING Lajos Pusztai
  • 784 views
  • June 17, 2024
  • 5
13:49

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NATALEE Trial - Baseline Characteristics and Efficacy Outcomes in N0 HR+/HER2- eBC"

FEATURING Denise Yardley
  • 858 views
  • June 7, 2024
  • 6
10:25

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ACE-Breast-02 Trial - ARX788 vs. Lapatinib + Capecitabine in HER2+ ABC"

FEATURING Xi-Chun Hu
  • 49 views
  • June 12, 2024
  • 1
07:20

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "I-SPY2.2 Trial - Rates of pCR After Neoadjuvant Datopotamab Deruxtecan for High-Risk Stage 2/3 BC"

FEATURING Jane Meisel
  • 221 views
  • June 13, 2024
  • 1
10:48

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PRIMED Trial - Prevention of SG-Related Neutropenia & Diarrhea in Patients With TNBC or HR+/HER2- Advanced BC"

FEATURING Antonio Llombart-Cussac
  • 378 views
  • June 11, 2024
  • 2
08:07

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "SACI-IO HR+ Trial - Sacituzumab Govitecan +/- Pembro in Patients With HR+/HER2- mBC"

FEATURING Ana Garrido-Castro
  • 274 views
  • June 13, 2024
  • 2
04:26

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "OPERA-01 Study - Palazestrant (OP-1250) vs. SoC for ER+/HER2- Advanced/Metastatic BC After ET & CDK4/6i"

FEATURING Barbara Pistilli
  • 38 views
  • June 11, 2024

GU

9329 views 697 hours watched
06:02

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Landscape Analysis & Oncologic Outcomes in Advanced Urothelial Carcinoma by NECTIN4 RNA Expression"

FEATURING Tyler Stewart
  • 11 views
  • September 25, 2024
21:54

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Prostate Cancer Take-Home Messages

FEATURING Eleni Efstathiou
  • 606 views
  • July 29, 2024
  • 2
10:19

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications for the Practicing Oncologist"

FEATURING Kriti Mittal
  • 363 views
  • July 16, 2024
  • 4
15:28

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Bladder and RCC Highlights"

FEATURING Karine Tawagi, Natalie Reizine
  • 262 views
  • July 16, 2024
  • 4
34:26

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Prostate Cancer Highlights"

FEATURING Natalie Reizine, Karine Tawagi
  • 566 views
  • July 10, 2024
  • 2
22:27

2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

FEATURING Guru Sonpavde
  • 533 views
  • July 5, 2024
  • 1
20:41

2024 ASCO® Annual Meeting Insights Hub

Bladder Cancer Highlights From ASCO® 2024

FEATURING Guru Sonpavde
  • 1,402 views
  • June 10, 2024
  • 9
09:00

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel + Abiraterone vs. Abiraterone Alone Post-Docetaxel for mCRPC"

FEATURING Christos Kyriakopoulos
  • 348 views
  • June 12, 2024
  • 2
19:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "A Clinical-Genetic ctDNA-Based Prognostic Model for Predicting OS in Men With mCRPC Treated With Potent AR Inhibition (Alliance)"

FEATURING Susan Halabi
  • 161 views
  • June 26, 2024
06:58

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very Favorable Risk mRCC - Real-World Evidence From the IMDC"

FEATURING Martin Zarba
  • 243 views
  • June 7, 2024
  • 1
07:29

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "MAST Study - Metformin in Reducing Progression Among Men on Expectant Management for Low-Risk Prostate Cancer"

FEATURING Neil Fleshner
  • 183 views
  • June 11, 2024
  • 1
07:26

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "TRANSFORMER Trial - Blood-Based Markers of Differential Efficacy of Bipolar Androgen Therapy and Enzalutamide in mCRPC"

FEATURING Emmanuel Antonarakis
  • 167 views
  • June 26, 2024
13:33

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Impact of Exposure on Outcomes With Enfortumab Vedotin in Patients With Locally Advanced or Metastatic Urothelial Cancer"

FEATURING Daniel Petrylak
  • 163 views
  • June 6, 2024
15:57

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment Strategies and QoL Impact in mCRPC - Key Updates From the MANCAN2, EMBARK, PRESTO, and PSMAfore Trials"

FEATURING Channing Paller
  • 170 views
  • June 26, 2024
  • 2
19:49

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Advances in RCC and Urothelial Carcinoma - Key Updates From the CheckMate 9ER, JAVELIN Renal 101, and CheckMate 901 Trials"

FEATURING Camillo Porta
  • 91 views
  • June 26, 2024
  • 1
17:44

ecancer

ASCO® 2024 Summary: "Expert Panel Discussion on the Real World Evidence on PSA Testing in Prostate Cancer"

FEATURING Friederike Schlürmann, Boris Hadaschik, Karim Fizazi
  • 192 views
  • June 24, 2024
22:22

ecancer

ASCO® 2024 Summary: "Expert Panel Discussion on Best Practices in HRRm Testing in Patients With Metastatic Prostate Cancer"

FEATURING Martin Schostak, Alexander Wyatt, Charles Ryan, Emmanuel Antonarakis
  • 181 views
  • June 24, 2024
05:44

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "KEYNOTE-426 Trial - Biomarker Analysis of Pembro + Axitinib vs. Sunitinib for aRCC"

FEATURING Brian Rini
  • 105 views
  • June 17, 2024
08:55

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Organ Preserving and Reconstructive Surgery in Penile Cancer"

FEATURING Arthur Burnett
  • 156 views
  • June 19, 2024
  • 1
09:15

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CYCLONE 2 Study - Abemaciclib + Abiraterone in mCRPC"

FEATURING Tilman Todenhöfer
  • 56 views
  • June 19, 2024
11:26

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Study EV-103 - Neoadjuvant Enfortumab Vedotin in Cisplatin-Ineligible MIBC Patients"

FEATURING Nataliya Mar
  • 136 views
  • June 21, 2024
  • 1
09:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "MANCAN2 Trial - Self-Help Cognitive Behavioural Therapy for Hot Flashes and Night Sweats in Patients With Prostate Cancer Receiving ADT"

FEATURING Simon Crabb
  • 131 views
  • June 17, 2024
04:41

ecancer

ASCO® 2024 Insights: "PSMAfore - HRQoL and Pain in Taxane-Naïve mCRPC Patients Treated with Lutetium-177-PSMA-617"

FEATURING Karim Fizazi
  • 79 views
  • June 20, 2024
10:35

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "EMBARK Post Hoc Analysis of Sexual Activity PROs in Patients Who Were Sexually Active or Interested in Sex at Baseline"

FEATURING Stephen Freedland
  • 144 views
  • June 5, 2024
  • 1
23:31

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Harnessing the Immune System in RCC - Current and Novel IO Approaches"

FEATURING David Braun
  • 196 views
  • June 7, 2024
09:35

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "EMBARK Study - Impact of Treatment Suspension on HRQoL in High-Risk BCR nmHSPC"

FEATURING Stephen Freedland
  • 161 views
  • June 13, 2024
  • 1
04:01

ecancer

ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel With Abiraterone vs. Abiraterone Alone in mCRPC Post Docetaxel"

FEATURING Christos Kyriakopoulos
  • 45 views
  • June 21, 2024
06:49

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcinoma"

FEATURING Eric Jonasch
  • 197 views
  • June 5, 2024
06:09

2024 ASCO® Annual Meeting Insights Hub

Efficacy & Toxicity of 177Lu-PSMA-617 for mCRPC in a Real-World Setting: Results From the U.S. Expanded Access Program and Comparisons With Phase 3 VISION Data

FEATURING Vishnu Murthy
  • 199 views
  • June 5, 2024
  • 1
04:16

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "KEYNOTE-361 Trial - Quantitative ctDNA Assessment in Patients With Advanced UC Treated With Pembro or Platinum-Based Chemo"

FEATURING Thomas Powles
  • 185 views
  • June 7, 2024
05:28

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ARV-766, a PROTAC Androgen Receptor Degrader, in mCRPC - Initial Results of a Phase 1/2 Study"

FEATURING Daniel Petrylak
  • 104 views
  • June 6, 2024
04:35

ecancer

ASCO® 2024 Insights: "SURE-01/02 Study - Perioperative Sacituzumab Govitecan +/- Pembro in MIBC"

FEATURING Antonio Cigliola
  • 46 views
  • June 20, 2024
06:27

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence for Oral and Injectable ADT in US Prostate Cancer Patients"

FEATURING Jason Hafron
  • 643 views
  • June 13, 2024
  • 1
09:54

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "1L Systemic Therapy Following Adjuvant IO in RCC"

FEATURING Talal El Zarif
  • 230 views
  • June 11, 2024
05:33

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Lenvatinib + Pembro vs. Sunitinib in aRCC - Patterns of Progression and Subsequent Therapy in the CLEAR Trial"

FEATURING Viktor Grünwald
  • 121 views
  • June 11, 2024
05:45

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer"

FEATURING Yu-Wei Chen
  • 135 views
  • June 11, 2024
04:59

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CORE-001 Study - Final Results of Cretostimogene Grenadenorepvec + Pembro in BCG-Unresponsive, High-Risk NMIBC With Carcinoma In Situ"

FEATURING Roger Li
  • 28 views
  • June 13, 2024
05:39

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ABBV-706 Study - Targeted ADC for Advanced Solid Tumors"

FEATURING Benjamin Garmezy
  • 42 views
  • June 11, 2024
10:50

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CA-62 - A New Biomarker for the Detection of Early Stage RCC"

FEATURING Evgueni Klinski
  • 27 views
  • June 11, 2024
06:42

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "AURA Trial Survival Data - Avelumab as Neoadjuvant Therapy in MIUC"

FEATURING Jeremy Blanc
  • 173 views
  • June 10, 2024
  • 2
06:52

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "HERCULES Trial - Pembro + Platinum-Based Chemo as 1L Treatment for Advanced Penile Cancer"

FEATURING Fernando Maluf
  • 95 views
  • June 10, 2024
13:42

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "KIM-1 Biomarker Analysis in IMmotion010 - Adjuvant Atezo vs. Placebo in RCC Patients at Increased Risk of Recurrence After Resection"

FEATURING Laurence Albiges
  • 64 views
  • June 7, 2024
05:52

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CheckMate 67T Trial - Safety & PROs of Subcutaneous vs. IV Nivo in Previously Treated Advanced or Metastatic ccRCC"

FEATURING Maria Bourlon
  • 94 views
  • June 7, 2024
10:02

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "LITESPARK-013 Study Subgroup Analysis - Belzutifan in Advanced ccRCC"

FEATURING Michael Atkins
  • 95 views
  • June 10, 2024

GI

7782 views 624 hours watched
VIDEO

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Botensilimab + Balstilimab in Microsatellite Stable mCRC - Assessing Efficacy in Non-Liver Metastatic Sites"

FEATURING Andrea Bullock
  • 125 views
  • August 1, 2024
12:27

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreatic Adenocarcinoma - Early Results From the PASS-01 Trial"

FEATURING Jennifer Knox
  • 164 views
  • July 9, 2024
12:29

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

FEATURING Cathy Eng
  • 203 views
  • July 9, 2024
  • 2
11:57

COR2ED The Heart of Medical Education

ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Cancer, NSCLC, HCC, and Upper-GI Cancers"

FEATURING Mark Socinski, Peter R. Galle, Shaheenah Dawood, Elizabeth Smyth, Samuel Klempner
  • 172 views
  • July 9, 2024
  • 3
15:55

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NETTER-2 Study - Efficacy and Safety of 177Lu-DOTA-TATE in Newly Diagnosed Advanced Grade 2/3 Gastroenteropancreatic NETs"

FEATURING Philip Philip
  • 87 views
  • July 8, 2024
08:19

COR2ED The Heart of Medical Education

ASCO® 2024 Summary: "Latest Practice-Changing Data in Gastroesophageal and Colorectal Cancers"

FEATURING Elizabeth Smyth, Samuel Klempner, Jenny Seligmann, Dominik Modest
  • 190 views
  • July 8, 2024
  • 1
10:27

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "EA2174 Study - Peri-Operative Nivo & Ipi for Locoregional Esophageal & GEJ Adenocarcinoma"

FEATURING Michael Gibson
  • 86 views
  • July 5, 2024
  • 1
08:08

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Atezo + Bev as 1L Systemic Therapy for aHCC - Outcomes Based on Child Pugh and ALBI Liver Function"

FEATURING Michael Storandt
  • 87 views
  • July 1, 2024
09:25

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including TRANSMET and ARC-9 Trials"

FEATURING Nataliya Uboha, Kristen Spencer, Michael Cecchini
  • 352 views
  • June 10, 2024
  • 1
12:50

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxel vs. 5-FU, Leucovorin, & Liposomal Irinotecan in Older Pts With Treatment-Naïve Metastatic Pancreatic Cancer"

FEATURING Efrat Dotan
  • 717 views
  • June 7, 2024
  • 3
09:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancers Including ESOPEC and ARMANI Trials"

FEATURING Nataliya Uboha, Anita Turk, Kristen Spencer, Michael Cecchini
  • 537 views
  • June 10, 2024
  • 4
04:01

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment for Advanced/Metastatic Esophageal SCC"

FEATURING Harry Yoon
  • 144 views
  • June 6, 2024
  • 3
26:40

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Experts Discuss Key Updates in Gastroesophageal Cancers"

FEATURING Aditya Shreenivas, Sakti Chakrabarti
  • 133 views
  • June 26, 2024
05:10

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "212Pb-DOTAMTATE, a Targeted Alpha Therapy for Pts With Unresectable or Metastatic SSTR+ GEP-NETs"

FEATURING Jonathan Strosberg
  • 201 views
  • June 6, 2024
  • 1
15:45

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Experts Discuss Key Updates in Colorectal Cancer"

FEATURING Sakti Chakrabarti, Aditya Shreenivas
  • 390 views
  • June 26, 2024
06:51

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Biliary Tract Cancer"

FEATURING Arndt Vogel
  • 91 views
  • June 25, 2024
07:37

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pembro in mPDAC"

FEATURING Benjamin Weinberg
  • 195 views
  • June 6, 2024
  • 1
09:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and CARES-310 Studies"

FEATURING Arndt Vogel
  • 213 views
  • June 25, 2024
  • 1
08:52

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Updates in Frontline Management of GE Cancers - Beyond PD-1"

FEATURING Raghav Sundar
  • 126 views
  • June 25, 2024
  • 1
27:39

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Upper-GI Key Studies Including ESOPEC and RENAISSANCE"

FEATURING Richard Kim, Rutika Mehta
  • 154 views
  • June 21, 2024
  • 2
01:47

ecancer

ASCO® 2024 Insights: "Comparing Preoperative Chemo to Neoadjuvant CRT in Patients With Esophageal Adenocarcinoma"

FEATURING Jens Hoeppner
  • 64 views
  • June 21, 2024
09:13

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary Cancer Including CheckMate 9DW and ABC-07 Trials"

FEATURING Nataliya Uboha, Kristen Spencer, Michael Cecchini
  • 230 views
  • June 10, 2024
  • 1
25:09

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

FEATURING Richard Kim, Tiago Biachi
  • 375 views
  • June 20, 2024
  • 1
24:57

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8HW, NEOPRISM, and PanaMa"

FEATURING Richard Kim, Tiago Biachi
  • 555 views
  • June 20, 2024
  • 4
04:25

ecancer

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel in De Novo Metastatic PDAC"

FEATURING Jennifer Knox
  • 196 views
  • June 20, 2024
12:32

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Time Dependency for HPV ctDNA Detection as a Prognostic Biomarker for Anal Cancer"

FEATURING Van Morris
  • 31 views
  • June 19, 2024
05:34

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "GABARNANCE Trial - Gemcitabine + nab-Paclitaxel vs. CRT With S-1 as Neoadjuvant Treatment for Borderline Resectable Pancreatic Cancer"

FEATURING Masafumi Ikeda
  • 40 views
  • June 18, 2024
17:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinical Utility of ctDNA"

FEATURING Stacey Cohen
  • 348 views
  • June 17, 2024
  • 1
06:51

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PanaMa Trial - FU/FA Maintenance Therapy With or Without Panitumumab in RAS Wild-Type mCRC"

FEATURING Dominik Modest
  • 306 views
  • June 10, 2024
  • 1
11:58

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "5-Year Results From the Randomized DYNAMIC Trial - ctDNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer"

FEATURING Jeanne Tie
  • 550 views
  • June 5, 2024
  • 6
03:22

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Efficacy, Safety, and PD of CM24 With Nivo & Chemo in Advanced/Metastatic Pancreatic Cancer"

FEATURING Teresa Macarulla
  • 148 views
  • June 5, 2024
11:42

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Atezolizumab & Varlilumab (CDX-1127) +/- Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer"

FEATURING Thatcher Heumann
  • 44 views
  • June 12, 2024
30:26

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NEOPRISM-CRC Trial - Neoadjuvant Pembro Stratified to TMB for High-Risk Stage 2 or 3 dMMR/MSI-High CRC"

FEATURING Kai-Keen Shiu
  • 88 views
  • June 12, 2024
  • 1
12:38

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Refining Treatment in Advanced Hepatobiliary Cancers"

FEATURING Laura Goff
  • 80 views
  • June 12, 2024
06:50

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "FIH Trial of M9140, an Anti-CEACAM5 ADC With Exatecan Payload, in Pts With mCRC"

FEATURING Scott Kopetz
  • 79 views
  • June 12, 2024
  • 1
05:56

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NETTER-2 Study - Safety & TTR of [177Lu]Lu-DOTATATE in Pts With Newly Diagnosed Advanced Grade 2 & 3, Well-Differentiated Gastroenteropancreatic NETs"

FEATURING Pamela Kunz
  • 43 views
  • June 12, 2024
08:19

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Randomized ARC-9 Study to Evaluate Etrumadenant-Based Combinations in Previously-Treated mCRC"

FEATURING Zev A. Wainberg
  • 69 views
  • June 10, 2024
  • 1
07:07

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ARMANI Trial - Ramucirumab + Paclitaxel as Switch Maintenance vs. Continuation of Oxaliplatin-Based Chemo in Patients With Advanced HER2- GC/GEJC"

FEATURING Filippo Pietrantonio
  • 103 views
  • June 10, 2024
  • 1
05:06

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CheckMate 8HW Trial - Nivo + Ipi With Chemo in 1L MSI-H/dMMR mCRC"

FEATURING Heinz-Josef Lenz
  • 66 views
  • June 10, 2024

Lung

6222 views 527 hours watched
17:22

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "SCLC Treatment Evolution - Debunking Myths, IO Advances, and Long-Term Strategies"

FEATURING Anne Chiang
  • 406 views
  • July 10, 2024
  • 2
40:00

ecancer

ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials

FEATURING Bishal Gyawali
  • 97 views
  • July 2, 2024
  • 1
04:26

ecancer

ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance vs. Local Consolidative Therapy in Limited mNSCLC"

FEATURING Puneeth Iyengar
  • 37 views
  • July 2, 2024
05:26

ecancer

ASCO® 2024 Lung Cancer Updates: CROWN, ADRIATIC, and LAURA Trials

FEATURING Luis Raez
  • 66 views
  • July 2, 2024
  • 1
03:04

ecancer

ASCO® 2024 Insights: "HARMONi-A Study - Ivonescimab + Chemo for EGFRm NSCLC Patients Who Progressed on EGFR-TKI Treatment"

FEATURING Li Zhang
  • 29 views
  • July 2, 2024
  • 1
19:33

ecancer

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

FEATURING Enriqueta Felip, Alex Spira, Antonio Passaro, Alfredo Addeo
  • 499 views
  • June 21, 2024
  • 1
16:10

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOMA-3 Trials

FEATURING Luis Raez
  • 679 views
  • June 14, 2024
  • 4
36:14

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, ADRIATIC, KRYSTAL-12, and LAURA Trials

FEATURING Balazs Halmos
  • 810 views
  • June 21, 2024
  • 11
11:45

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring KRASG12C Mutations"

FEATURING Tony Mok
  • 443 views
  • June 13, 2024
  • 1
07:06

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "RAGNAR Trial - Erdafitinib Efficacy & Safety in Advanced NSCLC With FGFR Alterations"

FEATURING Martin Schuler
  • 131 views
  • June 6, 2024
  • 1
05:13

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "SAVE Study - Comparing Suspension vs. Continuation of PD-1 Pathway Blockade in Advanced NSCLC"

FEATURING Yasushi Goto
  • 231 views
  • June 13, 2024
  • 3
12:10

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "BEAT Trials and Neoadjuvant Strategies - Advances in ES-SCLC and Mesothelioma Treatment"

FEATURING Melina Marmarelis
  • 247 views
  • June 20, 2024
  • 1
16:57

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NSCLC), HERKULES-3 Trial (CRC), Novel Agents in ER+/HER2- BC

FEATURING Vivek Subbiah
  • 678 views
  • June 14, 2024
  • 5
04:33

ecancer

ASCO® 2024 Insights: "ADRIATIC Study - Durvalumab as Consolidation Treatment After Concurrent Platinum-Based CRT for LS-SCLC"

FEATURING David Spigel
  • 74 views
  • June 21, 2024
12:19

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "TROPION-Lung05 Study - Intracranial Efficacy of Dato-DXd in Patients With Previously Treated Advanced/Metastatic NSCLC With Actionable Genomic Alterations"

FEATURING Aaron Lisberg
  • 193 views
  • June 21, 2024
  • 2
02:57

ecancer

ASCO® 2024 Insights: "LAURA Study - Osimertinib After Definitive CRT in Patients With Unresectable Stage 3 EGFRm NSCLC"

FEATURING Suresh Ramalingam
  • 60 views
  • June 21, 2024
04:52

ecancer

ASCO® 2024 Insights: "Telehealth Palliative Care for Advanced Lung Cancer - Effective Alternative to In-Person Visits"

FEATURING Joseph Greer
  • 25 views
  • June 20, 2024
  • 1
09:42

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "HARMONi-A Trial - Ivonescimab Combined With Chemo in Patients With EGFRm non-Squamous NSCLC Who Progressed on EGFR-TKI Treatment"

FEATURING Li Zhang
  • 126 views
  • June 17, 2024
  • 1
11:28

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ETOP 13-18 BEAT-meso Trial - Bevacizumab + Chemo +/- Atezolizumab as 1L Treatment for Advanced Pleural Mesothelioma"

FEATURING Sanjay Popat
  • 81 views
  • June 17, 2024
12:55

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "LIBRETTO-432 Trial - Adjuvant Selpercatinib vs. Placebo in Stage IB-IIIA RET+ NSCLC"

FEATURING Jonathan Goldman
  • 159 views
  • June 14, 2024
  • 1
02:26

ecancer

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring a KRASG12C Mutation"

FEATURING Robert Jotte
  • 188 views
  • June 21, 2024
  • 2
08:25

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CHRYSALIS-2 Trial - Amivantamab + Lazertinib in Atypical EGFRm Advanced NSCLC"

FEATURING Byoung Chul Cho
  • 64 views
  • June 14, 2024
09:34

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Assessing Secular Trends in Lung Cancer Stage in The United States Community Oncology Setting From 2013 to 2023"

FEATURING Jessica Paulus
  • 106 views
  • June 12, 2024
16:46

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance Systemic Therapy +/- Local Consolidative Therapy in Limited mNSCLC"

FEATURING Puneeth Iyengar
  • 80 views
  • June 13, 2024
06:53

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Impact on Biomarker Documentation in Community Oncology by Optimizing Clinical Decision Support for adjNSCLC, mNSCLC, and mCRPC"

FEATURING Daniel Rubin
  • 278 views
  • June 13, 2024
09:01

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Evolution Trial - RT-Free Pembro + Chemo in High PD-L1 LA-NSCLC"

FEATURING Akito Hata
  • 128 views
  • June 10, 2024
  • 2
08:29

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "MIST5 Trial - Niraparib & Dostarlimab in Platinum-Sensitive Relapsed Mesothelioma"

FEATURING Dean Fennell
  • 106 views
  • June 6, 2024
05:44

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Multi-Center Phase II Trial Investigating Safety & Efficacy of Osimertinib + Consolidative SABR in Advanced EGFRm NSCLC"

FEATURING Sawsan Rashdan
  • 49 views
  • June 10, 2024
  • 1
07:40

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PALOMA-2 Study - Subcutaneous Amivantamab & Lazertinib as 1L Treatment in Patients With EGFRm Advanced NSCLC"

FEATURING Sun Min Lim
  • 124 views
  • June 11, 2024
08:24

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "First-in-Human Trial of RSO-021 in Malignant Pleural Effusion Caused by Mesothelioma and Advanced Tumors"

FEATURING Dean Fennell
  • 28 views
  • June 6, 2024

Hematologic Oncology

7668 views 689 hours watched
06:26

ecancer

Post-Transplant Cyclophosphamide Based GVHD Prophylaxis in Patients Undergoing MMUD HCT

FEATURING Monzr Al Malki, Steven Devine
  • 42 views
  • July 24, 2024
09:04

ecancer

ASCO® 2024 Insights: "Importance of MRD in Newly Diagnosed Multiple Myeloma"

FEATURING Xavier Leleu
  • 77 views
  • July 18, 2024
  • 1
27:49

Insights from 2024 EHA Annual Meeting

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

FEATURING Talha Badar
  • 704 views
  • July 16, 2024
  • 4
11:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Benefit of R Maintenance After 1L BR in MCL"

FEATURING Yucai Wang
  • 69 views
  • July 11, 2024
  • 1
13:19

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CAPTIVATE Study - 5.5-Year Follow-Up Outcomes of Fixed-Duration Ibrutinib + Venetoclax in High-risk CLL/SLL"

FEATURING Ryan Jacobs
  • 182 views
  • July 8, 2024
  • 2
12:42

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Liso-Cel in R/R MCL With Prior BTKi Therapy - Results From TRANSCEND NHL 001"

FEATURING Leo Gordon
  • 57 views
  • June 30, 2024
16:57

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Lymphoma Highlights"

FEATURING Bruce D. Cheson
  • 1,237 views
  • June 19, 2024
  • 2
12:49

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment of Relapsed HL - Updated Options in Light of New Frontline Therapies"

FEATURING Patrick Johnson
  • 434 views
  • June 7, 2024
  • 5
13:15

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Quadruplets in NDMM - The More the Better?"

FEATURING Ola Landgren
  • 414 views
  • June 12, 2024
  • 7
19:14

2024 ASCO® Annual Meeting Insights Hub

Experts Discuss Highlights and Key Takeaways in CLL From ASCO® and EHA

FEATURING Kerry Rogers, Jennifer Woyach
  • 306 views
  • June 21, 2024
  • 1
36:10

Insights from 2024 EHA Annual Meeting

Highlights in Plasma Cell Disorders From ASCO® and EHA

FEATURING Samer Al Hadidi
  • 466 views
  • June 27, 2024
  • 7
12:37

ecancer

ASCO® 2024 Summary: "IMROZ & BENEFIT Studies in Newly Diagnosed Myeloma"

FEATURING Xavier Leleu
  • 182 views
  • June 24, 2024
  • 1
09:42

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis Following Mismatched Unrelated Donor PBSC Transplantation"

FEATURING Monzr Al Malki
  • 275 views
  • June 7, 2024
  • 3
17:07

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their Management With Bispecific Agents in MM and B-Cell NHL"

FEATURING Monique Minnema
  • 282 views
  • June 7, 2024
  • 4
11:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Glofitamab Monotherapy in Patients With Heavily Pretreated R/R MCL"

FEATURING Tycel Phillips
  • 61 views
  • June 25, 2024
08:30

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "DREAMM-7 Trial - BelamafVd vs. DaraVd in R/R MM"

FEATURING Maria-Victoria Mateos
  • 288 views
  • June 6, 2024
  • 1
16:56

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Sequencing Immunotherapy for Myeloma"

FEATURING Samir Parekh
  • 243 views
  • June 25, 2024
  • 4
02:54

ecancer

ASCO® 2024 Insights: "MajesTEC-7 Study - Safety and Efficacy of Tec-DR in NDMM"

FEATURING Salomon Manier
  • 67 views
  • June 26, 2024
03:48

ecancer

ASCO® 2024 Insights: "Results of Preliminary Safety & Efficacy of Belantamab Mafodotin and Elotuzumab in R/R MM"

FEATURING Natalia Neparidze
  • 73 views
  • June 25, 2024
08:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "TRANSFORM Study - 3-Year Follow-Up Comparing Liso-Cel vs. SoC With Salvage Chemo and ASCT as 2L Treatment in R/R LBCL"

FEATURING Manali Kamdar
  • 75 views
  • June 20, 2024
10:21

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "A Prospective Trial of Combining FDG-PET + Whole-Body MRI for Staging Newly Diagnosed and R/R Myeloma"

FEATURING Claudio Cerchione
  • 215 views
  • June 7, 2024
  • 1
14:58

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Optimal Treatment Strategies for Younger Patients With AML - Intensive vs. Non-Intensive Approaches"

FEATURING Christine McMahon
  • 288 views
  • June 20, 2024
  • 1
02:52

ecancer

ASCO® 2024 Insights: "Long-Term Follow-Up of MajesTEC-1 Trial - Teclistamab in R/R MM"

FEATURING Alfred Garfall
  • 23 views
  • June 20, 2024
03:48

ecancer

ASCO® 2024 Insights: "CARTITUDE-4 Study - Benefits of Ciltacabtagene Autoleucel in Lenalidomide-Refractory Functional High-Risk MM"

FEATURING Luciano Costa
  • 109 views
  • June 24, 2024
05:10

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Real World Outcomes of Pts With MM Who Received Bispecific Antibodies After CAR-T"

FEATURING Radhika Bansal
  • 128 views
  • June 19, 2024
05:26

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Indirect Comparison of Linvoseltamab Vs. Teclistamab for Triple-Class Exposed R/R MM"

FEATURING Sundar Jagannath
  • 182 views
  • June 17, 2024
  • 2
04:40

ecancer

ASCO® 2024 Insights: "PERSEUS Trial - MRD Analysis of Dara + VRd in Transplant-Eligible NDMM"

FEATURING Paula Rodríguez-Otero
  • 64 views
  • June 24, 2024
  • 1
14:59

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Current Status of Bispecific Antibody Therapy in R/R MM"

FEATURING Meera Mohan
  • 141 views
  • June 16, 2024
  • 1
16:18

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Understanding New Strategies to Prevent and Manage Chronic GVHD"

FEATURING Betty Hamilton
  • 70 views
  • June 16, 2024
13:47

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "MRD2STOP Study - Discontinuation of Maintenance Therapy in MM Guided by Multimodal MRD Negativity"

FEATURING Ben Derman
  • 395 views
  • June 11, 2024
  • 3
04:34

ecancer

ASCO® 2024 Insights: "IMROZ - A Ph3 Study of Isatuximab + VRd vs. VRd for Transplant-Ineligible NDMM"

FEATURING Thierry Facon
  • 106 views
  • June 24, 2024
21:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "The Art and Science of Caring for Older Adults With Myeloid Malignancies"

FEATURING Kah Poh Loh
  • 96 views
  • June 16, 2024
17:34

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment Considerations for Challenging Populations With Hodgkin Lymphoma"

FEATURING Cathy Burton
  • 115 views
  • June 10, 2024
14:02

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "New Agents on the Horizon in NHL and Myeloma - Targets Other Than CD3/CD20, New Constructs, and Trispecifics"

FEATURING Paolo Strati
  • 47 views
  • June 12, 2024
15:43

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The BENEFIT Study - Isa-VRd vs. Isa-Rd for Transplant-Ineligible NDMM"

FEATURING Xavier Leleu
  • 155 views
  • June 11, 2024

Skin

5194 views 535 hours watched
05:27

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker Analysis & Updated Clinical Outcomes - Neoadjuvant Systemic Treatment With Nivolumab and Relatlimab in Surgically Resectable Melanoma"

FEATURING Liz Burton
  • 129 views
  • July 22, 2024
35:23

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

FEATURING Sapna Patel
  • 771 views
  • July 11, 2024
  • 3
24:27

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuvant Treatments, 1L Metastatic & Anti-PD-1 Refractory Disease"

FEATURING Zeynep Eroglu
  • 326 views
  • July 5, 2024
  • 3
11:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and Refractory Melanoma"

FEATURING Douglas Johnson
  • 475 views
  • June 7, 2024
  • 1
25:29

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Insights in Melanoma"

FEATURING Omid Hamid
  • 459 views
  • June 21, 2024
  • 5
14:46

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Safety & Efficacy of First-in-Class CXCR1/2 Inhibitor SX-682 in Combination With Pembro in Patients With Metastatic Melanoma With Disease Progression on Anti-PD-1 Therapy"

FEATURING Sapna Patel
  • 60 views
  • June 19, 2024
11:27

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We Been and Where Are We"

FEATURING Pippa Corrie
  • 283 views
  • June 20, 2024
  • 1
02:57

ecancer

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi vs. Adjuvant Nivo in Stage III Melanoma"

FEATURING Christian Blank
  • 47 views
  • June 20, 2024
  • 1
15:18

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Adopting Cutting-Edge Cell Therapies in Melanoma"

FEATURING Allison Betof Warner
  • 190 views
  • June 11, 2024
03:12

ecancer

ASCO® 2024 Insights: "PIVOTAL Study - Neoadjuvant Daromun vs. Immediate Surgery in Fully Resectable Melanoma"

FEATURING Axel Hauschild
  • 37 views
  • June 20, 2024
09:13

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "QoL Data With Neoadjuvant Ipi & Nivo in Resectable Stage III Melanoma - 36-Week Data From the NADINA Trial"

FEATURING Judith Lijnsvelt
  • 57 views
  • June 14, 2024
  • 2
03:36

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PIVOTAL Study - Daromun vs. Immediate Surgery in Resectable Melanoma With Regional Metastases"

FEATURING Axel Hauschild
  • 65 views
  • June 11, 2024
09:54

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcomes - Nivo + Rela vs. Nivo for Previously Untreated Metastatic/Unresectable Melanoma"

FEATURING Hussein Tawbi
  • 390 views
  • June 12, 2024
  • 1
08:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in Macroscopic, Resectable Stage 3 Melanoma"

FEATURING Christian Blank
  • 263 views
  • June 14, 2024
  • 2
06:48

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "SCOPE Trial - Efficacy & Safety of SCIB1 Vaccine With Nivo & Ipi in Advanced Unresectable Melanoma"

FEATURING Heather Shaw
  • 21 views
  • June 13, 2024
14:01

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Macroscopic Stage III Melanoma and Immunotherapy - Pre-op, Post-op or No-op? NADINA Trial Discussion"

FEATURING Harriet Kluger
  • 123 views
  • June 10, 2024
  • 2
20:16

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Immunotherapy & Beyond - Advances in Systemic Therapy for Patients With Melanoma and Brain Metastases"

FEATURING Hussein Tawbi
  • 185 views
  • June 12, 2024
  • 1
11:33

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "PD-1-Refractory Advanced Melanoma - Getting to the Finish Line"

FEATURING Meredith Mckean
  • 145 views
  • June 10, 2024
  • 3
09:25

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NEO-TIM Trial - Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-Risk Resectable Melanoma"

FEATURING Paolo A. Ascierto
  • 39 views
  • June 12, 2024
09:31

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Roginolisib, an Oral, Highly Selective and Allosteric Modulator of PI3Kd for Uveal Melanoma and Advanced Cancers"

FEATURING Anna Maria Di Giacomo
  • 37 views
  • June 12, 2024
12:22

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "KEYNOTE-942 Trial - 3-Year Update on mRNA-4157 & Pembro in Resected Melanoma"

FEATURING Jeffrey Weber
  • 223 views
  • June 12, 2024
  • 1
11:34

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "RELATIVITY-048 Trial - Efficacy and Safety of Triplet Nivo + Rela + Ipi in Advanced Melanoma"

FEATURING Paolo A. Ascierto
  • 202 views
  • June 12, 2024
  • 3
10:17

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "RegoMel Trial - Regorafenib in Patients With Pretreated Advanced Melanoma"

FEATURING Iris Dirven
  • 32 views
  • June 7, 2024
08:10

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "OBX-115, IL2-Sparing Engineered TIL Cell Therapy for Immune Checkpoint Inhibitor-Resistant Unresectable/Metastatic Melanoma"

FEATURING Rodabe Amaria
  • 38 views
  • June 11, 2024
03:55

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib in Stage III BRAF-Mutated Melanoma"

FEATURING Axel Hauschild
  • 526 views
  • June 11, 2024
  • 1
01:52

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Individualized Neoantigen Therapy mRNA-4157 (V940) + Pembro in Resected Melanoma"

FEATURING Meredith Mckean
  • 31 views
  • June 11, 2024
07:38

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Novel RNA-Nanoparticle Vaccine for the Treatment of Early Melanoma Recurrence Following Adjuvant Anti-PD-1 Antibody Therapy"

FEATURING Bently Doonan
  • 40 views
  • June 6, 2024

GYN

3874 views 291 hours watched
18:51

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CARACO Trial - Omission of Lymphadenectomy in Advanced Epithelial Ovarian Cancer Treated With Primary or Interval Cytoreductive Surgery After Neoadjuvant Chemo"

FEATURING Jean-Marc Classe
  • 145 views
  • July 10, 2024
09:06

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

FEATURING Ritu Salani
  • 1,583 views
  • July 1, 2024
  • 12
13:15

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endometrial and Ovarian Cancers"

FEATURING Amer Karam
  • 421 views
  • June 26, 2024
  • 5
01:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Unveiling the Unique Identity of Clear-Cell Endometrial Cancer - A Comprehensive Comparative Analysis With Ovarian Counterpart and Other Endometrial Subtypes"

FEATURING Felix Blanc-Durand
  • 141 views
  • June 11, 2024
  • 1
14:45

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

FEATURING Mansoor Raza Mirza
  • 1,000 views
  • June 18, 2024
  • 5
05:00

ecancer

ASCO® 2024 Insights: "CARACO Trial - Omission of Lymphadenectomy in Advanced Epithelial Ovarian Cancer"

FEATURING Jean-Marc Classe
  • 139 views
  • June 21, 2024
  • 1
06:37

ecancer

ASCO® 2024 Insights: "Final OS & PFS From the AGO-OVAR 2.29/ENGOT-ov34 Study- Atezolizumab vs. Placebo in Combination With Bevacizumab + Chemo in Recurrent Ovarian Cancer"

FEATURING Frederik Marmé
  • 83 views
  • June 21, 2024
06:13

ecancer

ASCO® 2024 Insights: "BrUOG 354 Trial - Nivo Alone or in Combination With Ipi for People With Ovarian and Other Extra-Renal CCCs Who Had Relapsed After Prior Therapy"

FEATURING Don Dizon
  • 104 views
  • June 21, 2024
  • 1
14:40

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "BrUOG 354 Trial Final Results - Nivo vs. Nivo/Ipi for Ovarian & Other Extra-Renal Clear Cell Carcinomas"

FEATURING Don Dizon
  • 200 views
  • June 13, 2024
  • 1
08:31

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ALARICE Study - Avelumab With Axitinib in Persistent/Recurrent Cervical Cancer After Platinum-Based Chemo"

FEATURING Ka Yu Tse
  • 57 views
  • June 6, 2024

Head & Neck

2181 views 216 hours watched
19:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 H&N Cancer Highlights: Key Insights From Clinical Trials

FEATURING Katie Kerrigan
  • 194 views
  • August 27, 2024
08:06

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor Tovorafenib in R/R Pediatric Low Grade Glioma"

FEATURING David Ziegler
  • 145 views
  • July 11, 2024
  • 3
07:58

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Analyses of TTX-080, a First-in-Class HLA-G Antagonist, in Combination With Cetuximab in Patients With mCRC and HNSCC"

FEATURING Susanna Ulahannan
  • 44 views
  • July 3, 2024
06:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Petosemtamab With Pembro as 1L Treatment of Recurrent/Metastatic HNSCC"

FEATURING Cesar Perez
  • 85 views
  • July 3, 2024
21:12

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

FEATURING Nabil Saba
  • 1,030 views
  • June 13, 2024
  • 5
25:55

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "News in Head&Neck Cancers"

FEATURING Paolo Bossi
  • 483 views
  • June 14, 2024
  • 11
05:00

ecancer

ASCO® 2024 Insights: "E3311 Trial - Enhancing Oropharynx Cancer Outcomes With Transoral Surgery and Deintensified Post-Op Care"

FEATURING Barbara Burtness
  • 40 views
  • June 20, 2024
08:18

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Triple Oral Metronomic Therapy + Chemo Regimen vs. Chemo Alone in Advanced Unresectable HNSCC"

FEATURING Akhil Kapoor
  • 82 views
  • June 12, 2024
  • 2
07:05

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PRGN-2012, a Novel Gorilla Adenovirus-Based IO, Provides the First Treatment That Leads to Complete & Durable Responses in Recurrent Respiratory Papillomatosis Patients"

FEATURING Scott Norberg
  • 78 views
  • June 7, 2024
  • 1

Sarcoma

576 views 52 hours watched
18:08

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarcomas

FEATURING Atif Hussein
  • 158 views
  • August 12, 2024
  • 1
07:57

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Efficacy of Nirogacestat in Patients With Poor Prognostic Factors for Desmoid Tumors - Analyses From the DeFi Study"

FEATURING Bruno Vincenzi
  • 37 views
  • July 25, 2024
16:37

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Highlights in Sarcomas

FEATURING Robin Jones
  • 219 views
  • July 12, 2024
  • 1
02:27

ecancer

ASCO® 2024 Insights: "Monitoring Ovarian Function in DeFi Study - Nirogacestat in Desmoid Tumors"

FEATURING Elizabeth Loggers
  • 32 views
  • June 24, 2024
13:29

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Sorafenib Treatment Duration in Desmoid Tumors"

FEATURING Philippos Costa
  • 57 views
  • June 17, 2024
04:54

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Durvalumab & Tremelimumab vs. Doxorubicin in Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma"

FEATURING Viktor Grünwald
  • 73 views
  • June 12, 2024
  • 1